Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     

  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     

  • Bitcoin GBP

    51,076.40
    -497.71 (-0.97%)
     

  • CMC Crypto 200

    1,327.50
    -69.04 (-4.94%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     

  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Theranos reportedly had a secret partnership worth $350 million that has since fallen apart

Lydia Ramsey
safeway
safeway

(REUTERS/Rick Wilking )

Theranos and The Wall Street Journal have gone another round.

In the latest report from The Journal's John Carreyrou, published Tuesday night, current and former Safeway executives say its partnership with Theranos, the $9 billion startup that claims it can run blood tests with only a finger prick's worth of blood, is on the brink of officially dissolving.

The supermarket chain reportedly spent $350 million to put in Theranos testing clinics in more than 800 supermarkets, The Journal reports.

The company responded Tuesday night to Carreyrou's latest report with an online statement that read, "As we relayed to the Journal, the information published in this piece is again inaccurate, misleading and defamatory."

ADVERTISEMENT

So far, Theranos has partnered with Walgreens in Arizona and Capital BlueCross in Pennsylvania. A Journal article last month reported that the Theranos-Walgreens partnership had stalled until the blood-testing company could provide more information about its finger-prick tests.

Theranos CEO Elizabeth Holmes said after The Journal's report that this was the first she's heard of it. This back and forth between The Journal and Theranos began in October after a Journal article pointed out some inaccuracies in the company's test results. Business Insider reached out to Theranos for comment, and they directed us to their online statement.

The Journal reports the clinics that were meant for Theranos blood tests are now largely being used to administer flu shots and vaccines.

The partnership, which reportedly went by the code name "T-Rex," was never publicly acknowledged by either company.

NOW WATCH: NEW RESEARCH: 96% of the brains in an NFL study tested positive for disease



More From Business Insider